EBV (EBNA-3B) Peptide Pool, STEMCELL Technologies (CAT#: STEM-CT-0822-ZJF)

Stimulating T cells with EBV (EBNA-3B) Peptide Pool releases downstream cytokines and upregulates activation markers, enabling antigen-specific T cells to be detected or isolated for analysis. EBV (EBNA-3B) Peptide Pool is a lyophilized mixture of 234 peptides from Epstein-Barr nuclear antigen 3B (EBNA-3B) of Epstein-Barr virus (EBV; strain AG876) and consists of 15-mer peptides with 11-amino-acid overlaps that cover amino acids 1 - 946 on EBNA-3B. EBNA-3B is considered non-essential for B cell growth transformation (Chen et al., 2005; Tomkinson & Kieff), but has been shown to regulate the expression of cellular genes in EBV-infected cells (Chen at al., 2006). Viral peptide pools are useful for a broad range of applications, including vaccine development, immunological research, and diagnostic assay development.

Subtype: Peptide Pools
Species: Other
Application: Activation, Cell Culture
Area of Interest: Infectious Diseases
Purity: Average 70%

Reliable Consistency: Guarantees uniformity and repeatability in various applications with endotoxin levels below 0.2 EU/μg.
Free of Animal Components: Completely devoid of any animal or human-derived elements.
Broad Selection: Offers a wide range of human, mouse, and rat cytokines available in multiple sizes.

EBV (LMP2A) Peptide Pool, STEMCELL Technologies
EBV (LMP1) Peptide Pool, STEMCELL Technologies
EBV (EBNA-3A) Peptide Pool, STEMCELL Technologies
HIV-1 (B Gag) Peptide Pool, STEMCELL Technologies